You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Von Willebrand Factor antibody [F8/86] (ab778)

CodeSizePriceAbpoints Availability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Von Willebrand Factor antibody [F8/86]
See all Von Willebrand Factor products (23) ...

Description

Mouse monoclonal [F8/86] to Von Willebrand Factor

Specificity

This antibody reacts with Von Willebrand Factor in endothelial cells. It also reacts with megakaryocytes in human bone marrow. Please note this antibody has been cited as worked in Rabbit in PMID 18387175 but due to customer concerns regarding this we have changed it to predicted species.

Tested applications

IHC-P, IHC-Frmore details

Cross reactivity

Reacts with

Human

Predicted to work with

Rabbit

Immunogen

Von Willebrand Factor isolated from human plasma.

Properties

Form

Liquid

Storage instructions

Store at +4°C.

Storage buffer

Preservative: 0.05% Sodium Azide
Constituents: 1% BSA, Tissue culture supernatant

Purity

Tissue culture supernatant

Clonality

Monoclonal

Clone number

F8/86

Isotype

IgG1

Light chain type

kappa

  • Immunohistochemistry (Formalin-fixed paraffin-embedded sections) - Von Willebrand Factor antibody [F8/86] (ab778)Immunohistochemistry (Formalin-fixed paraffin-embedded sections) - Von Willebrand Factor antibody [F8/86] (ab778) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab778 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • ShowHide1 Image

    IHC-P

     IHC-P: 1/15 - 1/30.Perfo...Read more →

    IHC-P: 1/15 - 1/30.Perform enzymatic antigen retrieval before commencing with IHC staining protocol.

  • ShowHide

    IHC-Fr

     IHC-Fr: 1/15 - 1/30.(ABC...Read more →

    IHC-Fr: 1/15 - 1/30.(ABC method. We suggest an incubation period of 60 minutes at room temperature.)

Target

Function

Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma.

Tissue specificity

Plasma.

Involvement in disease

Defects in VWF are the cause of von Willebrand disease (VWD) [MIM:277480]. VWD defines a group of hemorrhagic disorders in which the von Willebrand factor is either quantitatively or qualitatively abnormal resulting in altered platelet function. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII and impaired platelet adhesion. Type I von Willebrand disease is the most common form and is characterized by partial quantitative plasmatic deficiency of an otherwise structurally and functionally normal Willebrand factor; type II is associated with a qualitative deficiency and functional anomalies of the Willebrand factor; type III is the most severe form and is characterized by total or near-total absence of Willebrand factor in the plasma and cellular compartments, also leading to a profound deficiency of plasmatic factor VIII.

Sequence similarities

Contains 1 CTCK (C-terminal cystine knot-like) domain.
Contains 4 TIL (trypsin inhibitory-like) domains.
Contains 3 VWFA domains.
Contains 3 VWFC domains.
Contains 4 VWFD domains.

Domain

The von Willebrand antigen 2 is required for multimerization of vWF and for its targeting to storage granules.

Post-translational
modifications

All cysteine residues are involved in intrachain or interchain disulfide bonds.
N- and O-glycosylated.

Cellular localization

Secreted. Secreted > extracellular space > extracellular matrix. Localized to storage granules.

Target information above from: UniProt accessionP04275 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Coagulation factor VIII antibody
  • F8VWF antibody
  • Factor VIII related antigen antibody
  • von Willebrand antigen 2 antibody
  • Von Willebrand antigen II antibody
  • Von Willebrand disease antibody
  • VWD antibody
  • VWF antibody
  • VWF_HUMAN antibody
see all

Anti-Von Willebrand Factor antibody [F8/86] images:

  Immunohistochemistry (Formalin-fixed paraffin-embedded sections) - Von Willebrand Factor antibody [F8/86] (ab778)

Immunohistochemistry (Formalin-fixed paraffin-embedded sections) - Von Willebrand Factor antibody [F8/86] (ab778)

Formalin fixed paraffin embedded human tonsil stained with Von Willebrand Factor using ABC and AEC chromogen.

References for Anti-Von Willebrand Factor antibody [F8/86] (ab778)

This product has been referenced in:

  • Chabot Set al. A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor. J Exp Med 208:973-86 (2011). IHC.Read more (PubMed: 21482699) »
  • Chen Xet al. Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J Neuroinflammation 5:12 (2008). IHC-Fr; Rabbit.Read more (PubMed: 18387175) »

See all 3 publications for this product

Publishing research using ab778? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"